A biopsychosocial model of resilience for breast cancer: A preliminary study in mainland China. (October 2018)

• Record Type: Journal Article
• Authors: Ye, Zeng Jie; Peng, Chao Hua; Zhang, Hao Wei; Liang, Mu Zi; Zhao, Jing Jing; Sun, Zhe; Hu, Guang Yun; Yu, Yuan Liang
• Is Part Of: European journal of oncology nursing. Volume 36(2018)
• Page Start: 95
• Page End: 102
• Publication Date: 2018-10
• Subjects: Breast cancer -- Oncology -- Resilience model -- SEM -- RM-BC -- Biopsychosocial adjustment -- Mainland China; Cancer -- Nursing -- Periodicals; Cancer -- Research -- Periodicals; Oncology -- Periodicals; Oncology Nursing -- Periodicals; Neoplasms -- nursing -- Periodicals; Cancer -- Soins infirmiers -- Périodiques; Cancer -- Recherche -- Périodiques; Cancérologie -- Périodiques; Verpleegkunde; Kanker; Cancer -- Nursing; Cancer -- Research; Oncology; Electronic journals; Periodicals; Electronic journals; 616.9940231
• DOI: 10.1016/j.ejon.2018.08.001
• Languages: English
• ISSNs: 1462-3889

Abstract

Abstract: Purpose: Patients diagnosed with breast cancer exhibited critical biopsychosocial functions following surgery or adjuvant treatment; therefore, it is important that they exhibit resilience. A Resilience Model for Breast Cancer (RM-BC) was developed using Chinese breast cancer patients to increase our understanding of how resilience outcomes are positively and negatively affected by protective and risk factors, respectively. Methods: Chinese women with breast cancer completed the questionnaires within 1 week of beginning treatment. Exploratory Structural Equation Modeling was used to evaluate the RM-BC using a sample size of 342 patients. Results: RM-BC suggested satisfactory goodness-of-fit indices and 67 percents of variance for resilience was explained. The Fit Indices for the measurement model were as follows: CFI = 0.909, GFI = 0.911, IFI = 0.897, NFI = 0.922, PNFI = 0.896, PCFI = 0.884, and RMSEA = 0.031. Three risk factors — emotional distress, physical distress, and intrusive thoughts — and four protective factors — self-efficacy, social support, courage-related strategy, and hope — were recognized. Conclusion: The resilience model allows for a better understanding of Chinese breast cancer patients' resilience integration while undergoing treatment and provides an effective structure for the development of resilience-focused interventions that are grounded in their experiences. A randomized trial has provided evidences of feasibility in Chinese women with breast cancer and the resilience model could be used as a useful framework for more resilience intervention in the future. Highlights: What is already known about the topic? - In Mainland China, about 210, 000 women with breast cancer will be confirmed in 2018 and China will have 2.5 million breast cancer survivors by 2021. - Patients diagnosed with breast cancer exhibited critical biopsychosocial functions following surgery or adjuvant treatment; therefore, it is important that they exhibit resilience. What This Study Adds: - Report an exploratory evaluation of the Resilience Model for Breast Cancer (RM-BC). - RM-BC allows for a better understanding of Chinese breast cancer patients' resilience integration while undergoing treatment. - Provide a theory framework for the development of resilience-focused interventions that are grounded in their experiences.